恶性肿瘤患者骨盆功能不全性骨折的18F-FDG PET/MRI影像特征分析

Analysis of 18F-FDG PET/MRI imaging characteristics of pelvic insufficiency fracture in patients with malignant tumors

  • 摘要:
    目的 探讨恶性肿瘤患者骨盆功能不全性骨折(PIF)18F-氟脱氧葡萄糖(FDG)PET/MRI的影像特征。
    方法 采用回顾性队列研究分析2018年3月至2023年12月于武汉大学人民医院行18F-FDG PET/MRI检查且经临床随访确诊为PIF的44例患者的临床资料及影像资料,其中男性8例、女性36例,年龄(63.3±8.3)岁。临床资料主要包括性别、年龄、女性患者月经状态、有无明显临床症状、恶性肿瘤病史及临床分期、盆腔放疗史、骨密度等。影像资料包括MRI图像特征(如病灶部位、骨折线及骨髓水肿、病变部位信号改变及形态特征、强化特征等)和PET图像特征(如病灶部位的18F-FDG摄取程度、摄取分布及摄取形态等)。
    结果  44例患者中,盆腔恶性肿瘤放疗后患者较为多见(34/44,77.3%),且多为高龄(29/44,65.9%),绝经后女性骨质疏松患者较为多见(35/44,79.5%)。患者多无明显临床症状(32/44,72.7%),仅有12例(12/44,27.3%)表现为腰骶部或髋部疼痛等不适,6例(6/44,13.6%)患者无盆腔恶性肿瘤。PIF病变部位以骶骨及骶髂关节面下(包括骶骨翼和髂骨耳状面)病变(73/111,65.8%)最为常见。PET/MRI图像主要表现为骶骨翼、骶椎椎体、髂骨可见条片状、斑片状T1加权成像(T1WI)低信号、T2加权成像高信号影,边界欠清晰,脂肪抑制序列呈高信号,增强扫描可见强化,病变周围软组织可见不同程度的骨髓水肿影,部分病灶可见“锯齿样”T1WI低信号骨折线影,且无溶骨性破坏及软组织肿块形成;病变区域18F-FDG呈轻至中度摄取增高,最大标准摄取值为2.7±1.1(范围1.0~5.7),18F-FDG摄取增高区域多平行于骶髂关节。
    结论 18F-FDG PET/MRI显像可以准确地显示恶性肿瘤患者PIF的病变位置、18F-FDG的摄取特征及MRI的多参数成像信息,有助于PIF的诊断及与骨转移瘤相鉴别。

     

    Abstract:
    Objective To discuss the imaging characteristics of pelvic insufficiency fracture (PIF) in patients with malignant tumors who underwent 18F-fluorodeoxyglucose (FDG) PET/MRI.
    Methods A retrospective cohort study was conducted on the analysis of clinical and imaging data of 44 patients with PIF confirmed by clinical follow-up, who underwent 18F-FDG PET/MRI examination at Renmin Hospital of Wuhan University between March 2018 and December 2023. The cohort included 8 males and 36 females, with a mean age of (63.3±8.3) years. Clinical data primarily included gender, age, menopausal status of female patients, presence or absence of significant clinical symptoms, history of malignant tumors and clinical staging, history of pelvic radiotherapy, and bone mineral density. Imaging data comprised MRI features, such as lesion location, fracture line, marrow edema, signal changes and morphological characteristics of lesions, enhancement features, and PET features, such as the degree, distribution, and pattern of 18F-FDG uptake at lesion location.
    Results Among the 44 patients, 34 (77.3%) had received radiotherapy for pelvic malignancies, and most of them were elderly (29/44, 65.9%). Postmenopausal women with osteoporosis were more common (35/44, 79.5%). Most patients presented with no significant clinical symptoms (32/44, 72.7%); only 12 patients (12/44, 27.3%) presented with discomfont such as lumbosacral or hip pain. Six patients (6/44, 13.6%) had no history of pelvic malignancy. Involvement of the sacrum and the lower surface of the sacroiliac joint (including the sacral ala and auricular surface of the ilium) is the most common location of PIF lesions (73/111, 65.8%). On PET/MRI, the main imaging findings included strip-like or patchy areas demonstrating T1 weighted imaging (T1WI) hypointensity and T2 weighted imaging hyperintensity within the sacral ala, sacral vertebral bodies, and ilium. The lesions exhibited ill-defined margins, appeared hyperintense on fat-suppressed sequences, and showed enhancement on post-contrast images. Varying degrees of bone marrow edema were observed in the surrounding soft tissues, and some lesions showed "serrated" T1WI low signal fracture line shadows. Notably, no osteolytic destruction or soft tissue mass formation was evident. In the involved regions, 18F-FDG uptake mildly or moderately increased, with a maximum standardized uptake value of 2.7±1.1 (range: 1.0–5.7). The lesion areas of increased 18F-FDG uptake were predominantly oriented parallel to the sacroiliac joints.
    Conclusions 18F-FDG PET/MRI can accurately identify the lesion location, characterize 18F-FDG uptake features, and provide multiparametric MRI information of PIF in patients with malignant tumor. This integrated approach facilitates the diagnosis of PIF and its differentiation from bone metastases.

     

/

返回文章
返回